Ludwig, H., Poenisch, W., Knop, S., Egle, A., Schreder, M., Lechner, D., . . . Zojer, N. (2019). Ixazomib–Thalidomide–Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma. Br J Cancer.
Chicago ZitierstilLudwig, Heinz, et al. "Ixazomib–Thalidomide–Dexamethasone for Induction Therapy Followed By Ixazomib Maintenance Treatment in Patients With Relapsed/refractory Multiple Myeloma." Br J Cancer 2019.
MLA ZitierstilLudwig, Heinz, et al. "Ixazomib–Thalidomide–Dexamethasone for Induction Therapy Followed By Ixazomib Maintenance Treatment in Patients With Relapsed/refractory Multiple Myeloma." Br J Cancer 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.